Application 091155
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 500MG;EQ 15MG BASE | No | No |
| 002 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 850MG;EQ 15MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-7677 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride | Teva Pharmaceuticals USA, | ANDA | Current |
| 0093-7678 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride | Teva Pharmaceuticals USA, | ANDA | Current |
| 42291-512 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride | AvKARE, Inc. | ANDA | Current |
| 42291-513 | Pioglitazone and Metformin Hydrochloride | Pioglitazone and Metformin Hydrochloride | AvKARE, Inc. | ANDA | Current |